Table 1 Potential actions of macrophage migration inhibitory factor in the pathogenesis of rheumatoid arthritis, systemic lupus erythematosus and atherosclerosis. The time course and selective ...
1. Cervera R, Khamashta MA, Font J, et al.: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on ...
SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.
There are several novel biomarkers that have been implicated in the pathogenesis of atherosclerosis in SLE. Before discussing these novel biomarkers, however, it may be helpful to understand the ...
The first published illustrations of lupus erythematosus were included in von Hebra's text, Atlas of Skin Diseases, published in 1856. The Neoclassical era of the history of lupus began in 1872 when ...
Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system lupus, can be challenging to diagnose because of the variability in how it manifests itself in different people. In a ...
The study detailed that an imbalance in macrophage polarization is linked ... including rheumatoid arthritis and systemic lupus erythematosus. It also confirmed that a concentration point can ...
Patients with systemic lupus erythematosus and allied autoimmune disorder have antibodies that react ... Microvesicles are also generated from other blood cells such as macrophages and endothelial ...
While there is no cure for lupus, various medications can help manage symptoms. These include antimalarials, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), immunosuppressants ...
There are some types that just affect skin, but the term is usually used to describe a more severe form of the condition - lupus erythematosus (SLE). That affects many parts of the body ...